Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.

Taispeáin leaganacha eile (1)

BACKGROUND: Neuromyelitis optica (NMO) is a severe autoimmune inflammatory disorder associated with considerable relapse-related disability. Immunosuppression is the mainstay of treatment but many patients do not tolerate first-line immunosuppressive agents, or experience ongoing relapses. OBJECTIV...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Kitley, J, Elsone, L, George, J, Waters, P, Woodhall, M, Vincent, A, Jacob, A, Leite, M, Palace, J
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2013

Míreanna comhchosúla

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2013)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2012)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2013)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
de réir: Elsone, L, et al.
Foilsithe / Cruthaithe: (2012)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2013)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2014)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2014)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
de réir: Waters, P, et al.
Foilsithe / Cruthaithe: (2015)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
de réir: Waters, P, et al.
Foilsithe / Cruthaithe: (2016)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2012)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2012)

Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
de réir: Elsone, L, et al.
Foilsithe / Cruthaithe: (2014)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
de réir: Leite, M, et al.
Foilsithe / Cruthaithe: (2009)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
de réir: Nour, M, et al.
Foilsithe / Cruthaithe: (2015)

Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom
de réir: Elsone, L, et al.
Foilsithe / Cruthaithe: (2013)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
de réir: Kim, S, et al.
Foilsithe / Cruthaithe: (2013)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2012)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
de réir: Waters, P, et al.
Foilsithe / Cruthaithe: (2008)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2014)

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
de réir: Wilson, R, et al.
Foilsithe / Cruthaithe: (2018)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2011)

PREGNANCY OUTCOME IN AQUAPORIN-4 POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: A MULTI-CENTER RETROSPECTIVE COHORT STUDY
de réir: Nour, M, et al.
Foilsithe / Cruthaithe: (2014)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
de réir: Paul, F, et al.
Foilsithe / Cruthaithe: (2007)

Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders
de réir: Cheng, F, et al.
Foilsithe / Cruthaithe: (2014)

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
de réir: Min, J, et al.
Foilsithe / Cruthaithe: (2010)

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
de réir: Palace, J, et al.
Foilsithe / Cruthaithe: (2010)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
de réir: Friedemann Paul, et al.
Foilsithe / Cruthaithe: (2007-04-01)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
de réir: Jarius, S, et al.
Foilsithe / Cruthaithe: (2008)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
de réir: Nour, M, et al.
Foilsithe / Cruthaithe: (2014)

Long term efficacy, adherence and reasons for discontinuation in 103 cases of neuromyelitis optica treated with azathioprine: a multicentre study from the United Kingdom
de réir: Elsone, L, et al.
Foilsithe / Cruthaithe: (2013)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2012)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
de réir: Jarius, S, et al.
Foilsithe / Cruthaithe: (2008)

Use of mitoxantrone in neuromyelitis optica.
de réir: Kitley, J, et al.
Foilsithe / Cruthaithe: (2011)

Seasonal pattern of variation in neuromyelitis optica relapses
de réir: Elsone, L, et al.
Foilsithe / Cruthaithe: (2012)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
de réir: Collongues, N, et al.
Foilsithe / Cruthaithe: (2013)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
de réir: Kim, S-M, et al.
Foilsithe / Cruthaithe: (2016)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
de réir: Cavus, F, et al.
Foilsithe / Cruthaithe: (2013)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
de réir: Kim, S-M, et al.
Foilsithe / Cruthaithe: (2017)